BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Research Triangle Ventures
Research Triangle Ventures, a venture capital firm, specialized in investing in seed and early stage technology companies located in North Carolina.
